Prognostic Relationship Between Two Serial Determinations of B-type Natriuretic Peptide and Medium-Long-term Events in Heart Transplantation

Journal of Heart and Lung Transplantation

Volumn 27, Issue 7, 2008, Pages 735-740

  Martínez Dolz, Luis ^a   Almenar, Luis ^a   Hervás, Isabel ^a   Moro, José ^a   Agüero, Jaime ^a   Sánchez Lázaro, Ignacio ^a   Mateo, Antonio ^a   Salvador, Antonio ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEART HEMODYNAMICS; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS;

EID: 45649083086     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.04.008     Document Type: Article

References (35)

1. Rodeheffer R.J. Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004?. J Am Coll Cardiol 44 (2004) 740-749
2. Osca J., Quesada A., Arnau M.A., et al. Brain natriuretic peptide. Diagnostic value in heart failure. Rev Esp Cardiol 55 (2002) 7-15
3. Yu C.M., Sanderson J.E., Shum I.O., et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J 17 (1996) 1694-1702
4. Lang C.C., Prasad N., McAlpine H.M., et al. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J 127 (1994) 1635-1636
5. Perna E.R., Macin S.M., Cimbaro Canella J.P., et al. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure. J Heart Lung Transplant 25 (2006) 1230-1240
6. Anand I.S., Fisher L.D., Chiang Y.T., et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107 (2003) 1278-1283
7. Sirgurdsson A., and Swedberg K. The role of neurohormonal activation in chronic heart failure and postmyocardial infarction. Am Heart J 132 (1996) 229-234
8. Richards A.M., Nicholls M.G., Yandle T.G., et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. Heart 81 (1999) 114-120
9. de Lemos J., Morrow D., Bentley J., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
10. Sabatine M., Morrow D., de Lemos J., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 1760-1763
11. Ishizaka Y., Yamamoto Y., Fukunaga T., et al. Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Am J Kidney Dis 24 (1994) 461-472
12. Jensen K.T., Carstens J., Ivarsen P., and Pedersen E.B. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 57 (1997) 529-540
13. Ationu A., Burch M., Singer D., Littleton P., and Carter N. Cardiac transplantation affects ventricular expression of brain natriuretic peptide. Cardiovasc Res 27 (1993) 188-191
14. Geny B., Follenius M., Epailly E., et al. Transient reduction without normalization of brain natriuretic peptide early after heart transplantation. J Thorac Cardiovasc Surg 115 (1998) 473-475
15. Park M.H., Scott R.L., Uber P.A., and Mehra M.R. Bedside B-type natriuretic peptide and acute non-cellular cardiac allograft rejection. J Heart Lung Transplant 21 (2002) 613-614
16. Arnau-Vives M., Almenar L., Hervas I., et al. Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection. J Heart Lung Transplant 23 (2004) 850-856
17. Hammerer-Lercher A., Mair J., Antretter H., et al. B-type natriuretic peptide as a marker of allograft rejection after heart transplantation. J Heart Lung Transplant 24 (2005) 1444
18. O'Neill J.O., McRae A.T., Troughton R.W., et al. Brain natriuretic peptide levels do not correlate with acute cellular rejection in de novo orthotopic heart transplant recipients. J Heart Lung Transplant 24 (2005) 416-420
19. Mehra M., Uber P., Potluri S., et al. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. Am J Cardiol 94 (2004) 454-458
20. Park M., Scott R., Uber P., et al. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function. Am J Cardiol 90 (2002) 1326-1329
21. Martínez-Dolz L., Almenar L., Moro J., et al. Prognostic value of BNP in heart transplant patients. J Heart Lung Transplant 26 (2007) 986-991
22. Shaw S.M., and Williams S.G. Is brain natriuretic peptide clinically useful after cardiac transplantation?. J Heart Lung Transplant 25 (2006) 1396-1401
23. Almenar L., Martinez-Dolz L., and Moro J. Natriuretic peptides and heart transplant. Curr Opin Mol Ther 9 (2007) 282-290
24. Gardner R.S., Chong K.S., Murday A.J., Morton J.J., and McDonagh T.A. N-terminal brain natriuretic peptide is predictive of death after cardiac transplantation. Heart 92 (2006) 121-123
25. Ambrosi P., Oddoze C., Riberi A., et al. Usefulness of N-terminal-pro-brain natriuretic peptide levels in predicting survival in heart transplant recipients. Am J Cardiol 94 (2004) 1585-1587
26. Kirchhoff W., Gradaus R., Stypmann J., et al. Vasoactive peptides during long-term follow-up of patients after cardiac transplantation. J Heart Lung Transplant 23 (2004) 284-288
27. Berger R., Huelsman M., Strecker K., et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105 (2002) 2392-2397
28. Bradley D.J., Bradley E.A., Baughman K.L., et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trial. JAMA 289 (2003) 730-740
29. Sinha A.M., Filzmaier K., Breithardt O.A., et al. Usefulness of brain natriuretic release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure. Am J Cardiol 91 (2003) 755-758
30. Buckley M.G., Sethi D., Markandu N.D., et al. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci 83 (1992) 437-444
31. El Gamel A., Yonan N.A., Keevil B., et al. Significance of raised natriuretic peptides after bicaval and standard cardiac transplantation. Ann Thorac Surg 63 (1997) 1095-1100
32. Burgess M.I., Bhattacharyya A., and Ray S.G. Echocardiography after cardiac transplantation. J Am Soc Echocardiogr 15 (2002) 917-925
33. Mehra R., Uber P., Walther D., et al. Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation. More than a hemodynamic marker. Circulation 114 suppl I (2006) I-21-I-26
34. Bettencourt P., Ferreira S., Azevedo A., and Ferreira A. Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcomes after hospital discharge in patients with heart failure. Am J Med 113 (2002) 215-219
35. Bettencourt P., Azevedo A., Pimenta J., et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 (2004) 2168-2174